Home > Insider Trading > Latest 13D and 13G Filings > 13D Filing (0001104659-24-042783)

Filing Details

Accession Number:: 0001104659-24-042783
Form Type:: 13D Filing
Publication Date:: 2024-04-01 20:00:00

Filed By:: Sante Health Ventures I Lp
Company:: Molecular Templates Inc. (NASDAQ:MTEM)
Filing Date:: 2024-04-02
SEC Url:: 13D Filing

Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name	Sole Voting Power	Sole Dispositive Power	Aggregate Amount Owned Power	Percent of Class
Sant Health Ventures I	407,773	407,773	407,773	6.2%
SHV Management Services	411,106	411,106	411,106	6.2%
Sant Health Ventures I Annex Fund	57,966	57,966	57,966	0.9%
SHV Annex Services	57,966	57,966	57,966	0.9%
SHV Management Services	469,072	469,072	469,072	7.1%
SHV MTEM SPV	175,000	175,000	175,000	2.7%
Sant Accel Ventures IV	175,000	175,000	175,000	2.7%
Sant Health Ventures IV	175,000	175,000	175,000	2.7%
SHV Management Services IV	175,000	175,000	175,000	2.7%
SHV Management Services IV	175,000	175,000	175,000	2.7%
Joe H. Cunningham	644,072	644,072	644,072	9.8%
Douglas D. French	644,072	644,072	644,072	9.8%
Kevin M. Lalande	665,538	665,538	665,538	10.1%

Filing

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 3)*

Molecular Templates, Inc.

(Name of Issuer)

Common stock, $0.001 par value per share

(Title of Class of Securities)

608550208

(CUSIP Number)

Jason Brandt

c/o Santé Ventures

201 West 5th Street, Suite 1500

Austin, Texas 78701

(512) 721-1200

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

April 2, 2024

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ¨

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 608550208
1.	Names of Reporting Persons Santé Health Ventures I, LP
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨      (b) x
3.	SEC Use Only
4.	Source of Funds (See Instructions) WC
5.	Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     ¨
6.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With		7.	Sole Voting Power 407,773 (1)
		8.	Shared Voting Power See response to row 7.
		9.	Sole Dispositive Power 407,773 (1)
		10.	Shared Dispositive Power See response to row 9.
11.	Aggregate Amount Beneficially Owned by Each Reporting Person 407,773
12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)     ¨
13.	Percent of Class Represented by Amount in Row (11) 6.2% (2)
14.	Type of Reporting Person (See Instructions) PN

(1)

Consists of 406,486 shares of common stock and 1,287 shares of common stock issuable upon exercise of warrants held directly by SHV I. SHV Services is the general partner of SHV I and SHV Management is the general partner of SHV Services. Each of SHV Services and SHV Management may be deemed to have sole voting and dispositive power over these shares. Cunningham, French and Lalande are the managing members of SHV Management and may be deemed to share voting and dispositive power over these shares.

(2)

This percentage is calculated based upon the sum of: (i) 5,374,268 shares of Common Stock outstanding as of March 25, 2024, as reported in the Issuer’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on March 19, 2024; (ii) 1,209,612 shares of Common Stock issued in the private placement of equity securities by the Issuer that closed on April 2, 2024 (the “2024 Private Placement”) as disclosed in the Issuer’s Current Report on Form 8-K filed with the SEC on March 28, 2024; and (iii) 1,287 shares of Common Stock issuable upon the exercise of the warrants.

CUSIP No. 608550208
1.	Names of Reporting Persons SHV Management Services, LP
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨     (b) x
3.	SEC Use Only
4.	Source of Funds (See Instructions) WC
5.	Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)    ¨
6.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With		7.	Sole Voting Power 411,106 (1)
		8.	Shared Voting Power See response to row 7.
		9.	Sole Dispositive Power 411,106 (1)
		10.	Shared Dispositive Power See response to row 9.
11.	Aggregate Amount Beneficially Owned by Each Reporting Person 411,106
12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)     ¨
13.	Percent of Class Represented by Amount in Row (11) 6.2% (2)
14.	Type of Reporting Person (See Instructions) PN

(1)

Consists of (i) 406,486 shares of common stock and 1,287 shares of common stock issuable upon exercise of warrants held directly by SHV I and (ii) 3,333 shares of common stock held directly by SHV Services. SHV Services is the general partner of SHV I and SHV Management is the general partner of SHV Services. Each of SHV Services and SHV Management may be deemed to have sole voting and dispositive power over these shares. Cunningham, French and Lalande are the managing members of SHV Management and may be deemed to share voting and dispositive power over these shares.

(2)

This percentage is calculated based upon the sum of: (i) 5,374,268 shares of Common Stock outstanding as of March 25, 2024, as reported in the Issuer’s Annual Report on Form 10-K filed with the SEC on March 19, 2024; (ii) 1,209,612 shares of Common Stock issued in the 2024 Private Placement as disclosed in the Issuer’s Current Report on Form 8-K filed with the SEC on March 28, 2024; and (iii) 1,287 shares of Common Stock issuable upon the exercise of the warrants.

CUSIP No. 608550208
1.	Names of Reporting Persons Santé Health Ventures I Annex Fund, LP
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨      (b) x
3.	SEC Use Only
4.	Source of Funds (See Instructions) WC
5.	Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)   ¨
6.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With		7.	Sole Voting Power 57,966 (1)
		8.	Shared Voting Power See response to row 7.
		9.	Sole Dispositive Power 57,966 (1)
		10.	Shared Dispositive Power See response to row 9.
11.	Aggregate Amount Beneficially Owned by Each Reporting Person 57,966
12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)      ¨
13.	Percent of Class Represented by Amount in Row (11) 0.9% (2)
14.	Type of Reporting Person (See Instructions) PN

(1)

Consists of 57,644 shares of common stock and 322 shares of common stock issuable upon exercise of warrants held directly by Annex Fund. Annex Services is the general partner of Annex Fund and SHV Management is the general partner of Annex Services. Each of Annex Services and SHV Management may be deemed to have sole voting and dispositive power over these shares. Cunningham, French and Lalande are the managing members of SHV Management and may be deemed to share voting and dispositive power over these shares.

(2)

This percentage is calculated based upon the sum of: (i) 5,374,268 shares of Common Stock outstanding as of March 25, 2024, as reported in the Issuer’s Annual Report on Form 10-K filed with the SEC on March 19, 2024; (ii) 1,209,612 shares of Common Stock issued in the 2024 Private Placement as disclosed in the Issuer’s Current Report on Form 8-K filed with the SEC on March 28, 2024; and (iii) 322 shares of Common Stock issuable upon the exercise of warrants

CUSIP No. 608550208
1.	Names of Reporting Persons SHV Annex Services, LP
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨    (b) x
3.	SEC Use Only
4.	Source of Funds (See Instructions) WC
5.	Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     ¨
6.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With		7.	Sole Voting Power 57,966 (1)
		8.	Shared Voting Power See response to row 7.
		9.	Sole Dispositive Power 57,966 (1)
		10.	Shared Dispositive Power See response to row 9.
11.	Aggregate Amount Beneficially Owned by Each Reporting Person 57,966
12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)    ¨
13.	Percent of Class Represented by Amount in Row (11) 0.9% (2)
14.	Type of Reporting Person (See Instructions) PN

(1)

(2)

This percentage is calculated based upon the sum of: (i) 5,374,268 shares of Common Stock outstanding as of March 25, 2024, as reported in the Issuer’s Annual Report on Form 10-K filed with the SEC on March 19, 2024; (ii) 1,209,612 shares of Common Stock issued in the 2024 Private Placement as disclosed in the Issuer’s Current Report on Form 8-K filed with the SEC on March 28, 2024; and (iii) 322 shares of Common Stock issuable upon the exercise of warrants.

CUSIP No. 608550208
1.	Names of Reporting Persons SHV Management Services, LLC
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨     (b) x
3.	SEC Use Only
4.	Source of Funds (See Instructions) WC
5.	Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     ¨
6.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With		7.	Sole Voting Power 469,072 (1)
		8.	Shared Voting Power See response to row 7.
		9.	Sole Dispositive Power 469,072 (1)
		10.	Shared Dispositive Power See response to row 9.
11.	Aggregate Amount Beneficially Owned by Each Reporting Person 469,072
12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)     ¨
13.	Percent of Class Represented by Amount in Row (11) 7.1% (2)
14.	Type of Reporting Person (See Instructions) OO

(1)

(2)

This percentage is calculated based upon the sum of: (i) 5,374,268 shares of Common Stock outstanding as of March 25, 2024, as reported in the Issuer’s Annual Report on Form 10-K filed with the SEC on March 19, 2024; (ii) 1,209,612 shares of Common Stock issued in the 2024 Private Placement as disclosed in the Issuer’s Current Report on Form 8-K filed with the SEC on March 28, 2024; and (iii) 1,609 shares of Common Stock issuable upon the exercise of warrants.

CUSIP No. 608550208
1.	Names of Reporting Persons SHV MTEM SPV, LLC
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨    (b) x
3.	SEC Use Only
4.	Source of Funds (See Instructions) WC
5.	Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     ¨
6.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With		7.	Sole Voting Power 175,000 (1)
		8.	Shared Voting Power See response to row 7.
		9.	Sole Dispositive Power 175,000 (1)
		10.	Shared Dispositive Power See response to row 9.
11.	Aggregate Amount Beneficially Owned by Each Reporting Person 175,000
12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)    ¨
13.	Percent of Class Represented by Amount in Row (11) 2.7% (2)
14.	Type of Reporting Person (See Instructions) OO

(1)

Shares are held directly by SHV SPV. Accel IV is the managing member of SHV SPV, SHV IV is the manager of Accel IV, SHV IV Services is the general partner of SHV IV and SHV IV Management is the general partner of SHV IV Services. Each of SHV IV, SHV IV Services and SHV IV Management may be deemed to have sole voting and dispositive power over thee shares. Cunningham, French and Lalande are the managing members of SHV IV Management and may be deemed to share voting and dispositive power over these shares. Excludes 2024 Pre-Funded Warrants and 2024 Common Warrants (each as defined herein) to purchase 402,077 shares of Common Stock and 1,154,154 shares of Common Stock, respectively, held by SHV SPV, which are not exercisable by virtue of a beneficial ownership limitation which prohibits the exercise of such warrants to the extent that such exercise would result in SHV SPV, together with its affiliates, beneficially owning greater than 9.99% of the outstanding Common Stock.

(2)

This percentage is calculated based upon the sum of: (i) 5,374,268 shares of Common Stock outstanding as of March 25, 2024, as reported in the Issuer’s Annual Report on Form 10-K filed with the SEC on March 19, 2024 and (ii) 1,209,612 shares of Common Stock issued in the 2024 Private Placement as disclosed in the Issuer’s Current Report on Form 8-K filed with the SEC on March 28, 2024.

CUSIP No. 608550208
1.	Names of Reporting Persons Santé Accel Ventures IV, LLC
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨     (b) x
3.	SEC Use Only
4.	Source of Funds (See Instructions) WC
5.	Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)    ¨
6.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With		7.	Sole Voting Power 175,000 (1)
		8.	Shared Voting Power See response to row 7.
		9.	Sole Dispositive Power 175,000 (1)
		10.	Shared Dispositive Power See response to row 9.
11.	Aggregate Amount Beneficially Owned by Each Reporting Person 175,000
12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)     ¨
13.	Percent of Class Represented by Amount in Row (11) 2.7% (2)
14.	Type of Reporting Person (See Instructions) OO

(1)

(2)

This percentage is calculated based upon the sum of: (i) 5,374,268 shares of Common Stock outstanding as of March 25, 2024, as reported in the Issuer’s Annual Report on Form 10-K filed with the SEC on March 19, 2024 and (ii) 1,209,612 shares of Common Stock issued in the 2024 Private Placement as disclosed in the Issuer’s Current Report on Form 8-K filed with the SEC on March 28, 2024.

CUSIP No. 608550208
1.	Names of Reporting Persons Santé Health Ventures IV, L.P.
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨    (b) x
3.	SEC Use Only
4.	Source of Funds (See Instructions) WC
5.	Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     ¨
6.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With		7.	Sole Voting Power 175,000 (1)
		8.	Shared Voting Power See response to row 7.
		9.	Sole Dispositive Power 175,000 (1)
		10.	Shared Dispositive Power See response to row 9.
11.	Aggregate Amount Beneficially Owned by Each Reporting Person 175,000
12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)     ¨
13.	Percent of Class Represented by Amount in Row (11) 2.7% (2)
14.	Type of Reporting Person (See Instructions) PN

(1)

(2)

This percentage is calculated based upon the sum of: (i) 5,374,268 shares of Common Stock outstanding as of March 25, 2024, as reported in the Issuer’s Annual Report on Form 10-K filed with the SEC on March 19, 2024 and (ii) 1,209,612 shares of Common Stock issued in the 2024 Private Placement as disclosed in the Issuer’s Current Report on Form 8-K filed with the SEC on March 28, 2024.

CUSIP No. 608550208
1.	Names of Reporting Persons SHV Management Services IV, LP
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨     (b) x
3.	SEC Use Only
4.	Source of Funds (See Instructions) WC
5.	Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)      ¨
6.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With		7.	Sole Voting Power 175,000 (1)
		8.	Shared Voting Power See response to row 7.
		9.	Sole Dispositive Power 175,000 (1)
		10.	Shared Dispositive Power See response to row 9.
11.	Aggregate Amount Beneficially Owned by Each Reporting Person 175,000
12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)      ¨
13.	Percent of Class Represented by Amount in Row (11) 2.7% (2)
14.	Type of Reporting Person (See Instructions) PN

(1)

(2)

This percentage is calculated based upon the sum of: (i) 5,374,268 shares of Common Stock outstanding as of March 25, 2024, as reported in the Issuer’s Annual Report on Form 10-K filed with the SEC on March 19, 2024 and (ii) 1,209,612 shares of Common Stock issued in the 2024 Private Placement as disclosed in the Issuer’s Current Report on Form 8-K filed with the SEC on March 28, 2024.

CUSIP No. 608550208
1.	Names of Reporting Persons SHV Management Services IV, LLC
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨     (b) x
3.	SEC Use Only
4.	Source of Funds (See Instructions) WC
5.	Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)      ¨
6.	Citizenship or Place of Organization Delaware
Number of Shares Beneficially Owned by Each Reporting Person With		7.	Sole Voting Power 175,000 (1)
		8.	Shared Voting Power See response to row 7.
		9.	Sole Dispositive Power 175,000 (1)
		10.	Shared Dispositive Power See response to row 9.
11.	Aggregate Amount Beneficially Owned by Each Reporting Person 175,000
12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)       ¨
13.	Percent of Class Represented by Amount in Row (11) 2.7% (2)
14.	Type of Reporting Person (See Instructions) OO

(1)

Shares are held directly by SHV SPV. Accel IV is the managing member of SHV SPV, SHV IV is the manager of Accel IV, SHV IV Services is the general partner of SHV IV and SHV IV Management is the general partner of SHV IV Services. Each of SHV IV, SHV IV Services and SHV IV Management may be deemed to have sole voting and dispositive power over thee shares. Cunningham, French and Lalande are the managing members of SHV IV Management and may be deemed to share voting and dispositive power over the shares held by SHV I, Annex Fund and Annex Services. Excludes 2024 Pre-Funded Warrants and 2024 Common Warrants (each as defined herein) to purchase 402,077 shares of Common Stock and 1,154,154 shares of Common Stock, respectively, held by SHV SPV, which are not exercisable by virtue of a beneficial ownership limitation which prohibits the exercise of such warrants to the extent that such exercise would result in SHV SPV, together with its affiliates, beneficially owning greater than 9.99% of the outstanding Common Stock.

(2)

This percentage is calculated based upon the sum of: (i) 5,374,268 shares of Common Stock outstanding as of March 25, 2024, as reported in the Issuer’s Annual Report on Form 10-K filed with the SEC on March 19, 2024 and (ii) 1,209,612 shares of Common Stock issued in the 2024 Private Placement as disclosed in the Issuer’s Current Report on Form 8-K filed with the SEC on March 28, 2024.

CUSIP No. 608550208
1.	Names of Reporting Persons Joe H. Cunningham
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨      (b) x
3.	SEC Use Only
4.	Source of Funds (See Instructions) AF
5.	Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)      ¨
6.	Citizenship or Place of Organization United States
Number of Shares Beneficially Owned by Each Reporting Person With		7.	Sole Voting Power 644,072 (1)
		8.	Shared Voting Power See response to row 7.
		9.	Sole Dispositive Power 644,072 (1)
		10.	Shared Dispositive Power See response to row 9.
11.	Aggregate Amount Beneficially Owned by Each Reporting Person 644,072
12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)      ¨
13.	Percent of Class Represented by Amount in Row (11) 9.8% (2)
14.	Type of Reporting Person (See Instructions) IN

(1)

Consists of (i) 406,486 shares of common stock and 1,287 shares of common stock issuable upon exercise of warrants held directly by SHV I; (ii) 3,333 shares of common stock held directly by SHV Services; (iii) 57,644 shares of common stock and 322 shares of common stock issuable upon exercise of warrants held directly by Annex Fund; and (iv) 175,000 shares of common stock held directly by SHV SPV. SHV Services is the general partner of SHV I and may be deemed to have sole voting and dispositive power over the shares held by SHV I. Annex Services is the general partner of Annex Fund and may be deemed to have sole voting and dispositive power over the shares held by Annex Fund. SHV Management is the general partner of each of SHV Services and Annex Services and may be deemed to have sole voting and dispositive power over the shares held by SHV I and Annex Fund. Accel IV is the managing member of SHV SPV, SHV IV is the manager of Accel IV, SHV IV Services is the general partner of SHV IV and SHV IV Management is the general partner of SHV IV Services. Each of SHV IV, SHV IV Services and SHV IV Management may be deemed to have sole voting and dispositive power over the shares held by SHV SPV. Cunningham, French and Lalande are the managing members of each of SHV Management and SHV IV Management and may be deemed to share voting and dispositive power over the shares held by SHV I, SHV Services, Annex Fund, and SHV SPV. Excludes 2024 Pre-Funded Warrants and 2024 Common Warrants (each as defined herein) to purchase 402,077 shares of Common Stock and 1,154,154 shares of Common Stock, respectively, held by SHV SPV, which are not exercisable by virtue of a beneficial ownership limitation which prohibits the exercise of such warrants to the extent that such exercise would result in SHV SPV, together with its affiliates, beneficially owning greater than 9.99% of the outstanding Common Stock.

(2)

This percentage is calculated based upon the sum of: (i) 5,374,268 shares of Common Stock outstanding as of March 25, 2024, as reported in the Issuer’s Annual Report on Form 10-K filed with the SEC on March 19, 2024; (ii) 1,209,612 shares of Common Stock issued in the 2024 Private Placement as disclosed in the Issuer’s Current Report on Form 8-K filed with the SEC on March 28, 2024; and (iii) 1609 shares of Common Stock issuable upon the exercise of the warrants.

CUSIP No. 608550208
1.	Names of Reporting Persons Douglas D. French
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨     (b) x
3.	SEC Use Only
4.	Source of Funds (See Instructions) AF
5.	Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     ¨
6.	Citizenship or Place of Organization United States
Number of Shares Beneficially Owned by Each Reporting Person With		7.	Sole Voting Power 644,072 (1)
		8.	Shared Voting Power See response to row 7.
		9.	Sole Dispositive Power 644,072 (1)
		10.	Shared Dispositive Power See response to row 9.
11.	Aggregate Amount Beneficially Owned by Each Reporting Person 644,072
12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)       ¨
13.	Percent of Class Represented by Amount in Row (11) 9.8% (2)
14.	Type of Reporting Person (See Instructions) IN

(1)

(2)

This percentage is calculated based upon the sum of: (i) 5,374,268 shares of Common Stock outstanding as of March 25, 2024, as reported in the Issuer’s Annual Report on Form 10-K filed with the SEC on March 19, 2024; (ii) 1,209,612 shares of Common Stock issued in the 2024 Private Placement as disclosed in the Issuer’s Current Report on Form 8-K filed with the SEC on March 28, 2024; and (iii) 1609 shares of Common Stock issuable upon the exercise of the warrants.

CUSIP No. 608550208
1.	Names of Reporting Persons Kevin M. Lalande
2.	Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨     (b) x
3.	SEC Use Only
4.	Source of Funds (See Instructions) AF
5.	Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)      ¨
6.	Citizenship or Place of Organization United States
Number of Shares Beneficially Owned by Each Reporting Person With		7.	Sole Voting Power 665,538 (1)
		8.	Shared Voting Power See response to row 7.
		9.	Sole Dispositive Power 665,538 (1)
		10.	Shared Dispositive Power See response to row 9.
11.	Aggregate Amount Beneficially Owned by Each Reporting Person 665,538
12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)      ¨
13.	Percent of Class Represented by Amount in Row (11) 10.1% (2)
14.	Type of Reporting Person (See Instructions) IN

(1)

Consists of (i) 406,486 shares of common stock and 1,287 shares of common stock issuable upon exercise of warrants held directly by SHV I; (ii) 3,333 shares of common stock held directly by SHV Services; (iii) 57,644 shares of common stock and 322 shares of common stock issuable upon exercise of warrants held directly by Annex Fund; (iv) 175,000 shares of common stock held directly by SHV SPV; (v) 14,800 shares of common stock directly by SHVMS, LLC; and (vi) 6,666 shares of Common Stock issuable upon exercise of stock options. SHV Services is the general partner of SHV I and may be deemed to have sole voting and dispositive power over the shares held by SHV I. Annex Services is the general partner of Annex Fund and may be deemed to have sole voting and dispositive power over the shares held by Annex Fund. SHV Management is the general partner of each of SHV Services and Annex Services and may be deemed to have sole voting and dispositive power over the shares held by SHV I and Annex Fund. Accel IV is the managing member of SHV SPV, SHV IV is the manager of Accel IV, SHV IV Services is the general partner of SHV IV and SHV IV Management is the general partner of SHV IV Services. Each of SHV IV, SHV IV Services and SHV IV Management may be deemed to have sole voting and dispositive power over the shares held by SHV SPV. Cunningham, French and Lalande are the managing members of each of SHV Management and SHV IV Management and may be deemed to share voting and dispositive power over the shares held by SHV I, SHV Services, Annex Fund, and SHV SPV. Lalande is a managing member of SHVMS, LLC and may be deemed to have voting and dispositive power over the shares held by SHVMS, LLC. Excludes 2024 Pre-Funded Warrants and 2024 Common Warrants (each as defined herein) to purchase 402,077 shares of Common Stock and 1,154,154 shares of Common Stock, respectively, held by SHV SPV, which are not exercisable by virtue of a beneficial ownership limitation which prohibits the exercise of such warrants to the extent that such exercise would result in SHV SPV, together with its affiliates, beneficially owning greater than 9.99% of the outstanding Common Stock.

(2)

This percentage is calculated based upon the sum of: (i) 5,374,268 shares of Common Stock outstanding as of March 25, 2024, as reported in the Issuer’s Annual Report on Form 10-K filed with the SEC on March 19, 2024; (ii) 1,209,612 shares of Common Stock issued in the 2024 Private Placement as disclosed in the Issuer’s Current Report on Form 8-K filed with the SEC on March 28, 2024; (iii) 1,609 shares of Common Stock issuable upon the exercise of the warrants; and (iv) 6,666 shares of Common Stock issuable upon exercise of stock options.

Explanatory Note: This Amendment No. 3 (“Amendment No. 3”), which amends the Schedule 13D filed with the Securities and Exchange Commission (the “SEC”) on August 14, 2017 and amended on May 4, 202 and September 18, 2020 (the “Original Schedule 13D”) filed on behalf of Santé Health Ventures I, LP, SHV Management Services, LP, Santé Health Ventures I Annex Fund, LP, SHV Annex Services, LP, SHV Management Services, LLC, Joe H. Cunningham, Douglas D. French and Kevin M. Lalande, relates to the common stock, par value $0.001 per share (the “Common Stock”), of Molecular Templates, Inc., a Delaware corporation (the “Issuer”). Unless otherwise defined herein, capitalized terms used in this Amendment No. 3 shall have the meanings ascribed to them in the Original Schedule 13D. This Amendment No. 3 is being filed to report the acquisition of securities by SHV SPV (as defined below) in the 2024 Private Placement (as defined below).

The share numbers in this Amendment No. 3 also give effect to a 1-for-15 reverse split of the outstanding shares of the Issuer’s Common Stock effected on August 11, 2023.

Except as amended hereby, the Original Schedule 13D remains in full force and effect.

Item 2.

Identity and Background

Item 2 of the Statement is hereby amended and restated as follows:

(a)

The persons and entities filing this Schedule 13D are Santé Health Ventures I, L.P. (“SHV I”), a Delaware limited partnership, SHV Management Services, LP (“SHV Services”), a Delaware limited partnership, SHV Management Services, LLC (“SHV Management”), a Delaware limited liability company, Sante Health Ventures I Annex Fund, L.P. (“Annex Fund”), a Delaware limited partnership, SHV Annex Services, LP (“Annex Services”), a Delaware limited partnership, SHV MTEM SPV, LLC (“SHV SPV”), a Delaware limited liability company, Santé Accel Ventures IV, LLC (“Accel IV”), a Delaware limited liability company, Santé Health Ventures IV, L.P. (“SHV IV”), a Delaware limited partnership, SHV Management Services IV, LP (“SHV IV Services”), a Delaware limited partnership, SHV Management Services IV, LLC (“SHV IV”), a Delaware limited liability company, Joe H. Cunningham (“Cunningham”), Douglas D. French (“French”) and Kevin Lalande (“Lalande” and, collectively, the “Reporting Persons”). SHV Services is the general partner of SHV I and Annex Services is the general partner of Annex Fund. SHV Management is the general partner of each of SHV Services and Annex Services. SHV IV is the managing member of SHV SPV, SHV IV Services is the general partner of SHV IV and SHV IV Management is the general partner of SHV IV Services. Cunningham, French and Lalande are the managing members of each SHV Management and SHV IV Management and may be deemed to share voting and dispositive power over the shares directly held by SHV I, SHV Services, Annex Fund and SHV SPV. Lalande is a managing member of SHVMS, LLC and may be deemed to have voting and dispositive power over the shares held by SHVMS, LLC.

(b)

The address of the principal place of business for each of the Reporting Persons is c/o Santé Ventures, 201 West 5th Street, Suite 1500, Austin, Texas 78701.

(c)

The principal occupation of each of the Reporting Persons is the venture capital investment business. The principal business of each of SHV I, Annex Fund, SHV SPV and SHV IV is to make investments in private and public companies. The principal business of SHV Services is to serve as the general partner of SHV I. The principal business of SHV Annex Services is to serve as the general partner of Annex Fund. The principal business of SHV Management is to serve as the general partner of each of SHV Services and Annex Services. The principal business of SHV IV Services is to serve as the general partner of SHV IV. The principal business of SHV IV Management is to serve as the general partner of SHV IV Services. Cunningham, French and Lalande are collectively the members of each of SHV Management and SHV Management IV.

(d)

During the last five years, none of the Reporting Persons has been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors).

(e)

During the last five years, none of the Reporting Persons has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

(f)

Each of SHV I, SHV Services, Annex Fund, Annex Services, SHV IV and SHV IV Services is a Delaware limited partnership. Each of SHV Management, SHV IV Management and SHV SPV is a Delaware limited liability company. Cunningham, French and Lalande are all U.S. citizens.

Item 3.

Source and Amount of Funds or Other Consideration

Item 3 of the Statement is hereby amended and supplemented to add the following:

On March 28, 2024, SHV SPV entered into an Amended and Restated Securities Purchase Agreement (the “2024 Securities Purchase Agreement”) with the Issuer to purchase (i) 175,000 shares of the Issuer’s Common Stock (the “2024 Shares”); (ii) pre-funded warrants (the “2024 Pre-Funded Warrants”) to purchase 402,077 shares of Common Stock; and (iii) common warrants (the “2024 Common Warrants”) to purchase 1,154,154 shares of Common Stock in a private offering (the “2024 Private Placement”) for an aggregate purchase price of $1.5 million. SHV SPV received the 2024 Shares and 2024 Pre-Funded Warrants and 2024 Common Warrants on April 2, 2024 (the “Closing Date”) pursuant to the closing of the 2024 Private Placement.

The funds used by SHV SPV to acquire the securities of the Issuer described herein were from capital contributions made by its members.

Item 5.

Interest in Securities of the Issuer

	(a) – (b).	Regarding aggregate beneficial ownership, see Row 11 of the cover page of each Reporting Person. Regarding percentage beneficial ownership, see Row 13 of the cover page of each Reporting Person.

		Regarding sole power to vote shares, see Row 7 of the cover page of each Reporting Person. Regarding shared power to vote shares, see Row 8 of the cover page of each Reporting Person. Regarding sole power to dispose of shares, see Row 9 of the cover page of each Reporting Person. Regarding shared power to dispose of shares, see Row 10 of the cover page of each Reporting Person.

(c)

Except as set forth above, the Reporting Persons have not effected any transaction in the Common Stock of the Issuer during the past 60 days.

(d)

No person (other than the Reporting Persons) is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock subject to this Schedule 13D.

(e)

Not applicable.

Item 6.

Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

Item 6 of the Statement is hereby amended and supplemented to add the following:

The information set forth in Item 3 this Amendment No. 3 is incorporated herein by reference.

Securities Purchase Agreement

Pursuant to the Securities Purchase Agreement, the Issuer granted to the purchasers, including SHV SPV, certain registration rights, pursuant to which, among other things, the Issuer will (i) file with the SEC a registration statement on Form S-3 after the closing of the 2024 Private Placement to register for resale the Shares (and the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants and Common Warrants ) issued in the 2024 Private Placement, within 30 calendar days following the Closing Date, and (ii) use its commercially reasonable efforts to have the registration statement declared effective as soon as practicable, and in any event no later than 90 days following the Closing Date (or 120 days following the Closing Date if the registration statement is reviewed by the SEC). The registration rights covenants are subject to customary terms and conditions for a transaction of this type, including certain customary cash penalties on the Issuer for its failure to satisfy specified filing and effectiveness time periods.

The foregoing description is qualified in its entirety by the full text of the form of Securities Purchase Agreement, which is filed herewith as Exhibit 11 and incorporated herein by reference.

2024 Common Warrants

Each 2024 Common Warrant has an exercise price of $2.35 per share of Common Stock, is immediately exercisable and has a term of five years. Under the terms of the 2024 Common Warrants, the 2024 Common Warrants may not be exercised if the aggregate number of shares of Common Stock beneficially owned by SHV SPV (together with its affiliates) immediately following such exercise would exceed a beneficial ownership limitation 9.99%; provided, however, that SHV SPV may increase or decrease the beneficial ownership limitation by giving 61 days’ notice to the Issuer, but not to any percentage in excess of 19.99%. By virtue of this limitation, as of the date hereof, the 2024 Common Warrants held by SHV SPV are not currently exercisable within 60 days and, therefore, the shares issuable upon exercise of the 2024 Common Warrants are not considered to be beneficially owned by the Reporting Persons.

The foregoing description is qualified in its entirety by the full text of the Form of Common Warrant, which is filed herewith as Exhibit 12 and incorporated herein by reference.

2024 Pre-Funded Warrant to Purchase Common Stock

Each 2024 Pre-Funded Warrant has an exercise price of $2.349 per Pre-Funded Warrant, is immediately exercisable and has no expiration date. Under the terms of the 2024 Pre-Funded Warrants, the 2024 Pre-Funded Warrants may not be exercised if the aggregate number of shares of Common Stock beneficially owned by SHV SPV (together with its affiliates) immediately following such exercise would exceed a beneficial ownership limitation 9.99%; provided, however, that SHV SPV may increase or decrease the beneficial ownership limitation by giving 61 days’ notice to the Issuer, but not to any percentage in excess of 19.99%. By virtue of this limitation, as of the date hereof, the 2024 Pre-Funded Warrants held by SHV SPV are not currently exercisable within 60 days and, therefore, the shares issuable upon exercise of the 2024 Common Warrants are not considered to be beneficially owned by the Reporting Persons.

The foregoing description is qualified in its entirety by the full text of the Form of Prefunded Warrant to Purchase Common Stock, which is filed herewith as Exhibit 13 and incorporated herein by reference.

Item 7.

Material to be Filed as Exhibits

Item 7 of the Statement is hereby amended and supplemented to add the following:

Exhibit 1	Joint Filing Agreement as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.

Exhibit 11	Amended and Restated Securities Purchase Agreement dated March 28, 2024 (incorporated by reference to Exhibit 4.1 to the Issuer’s Form 8-K (File No. 001-32979), filed on March 28, 2024).

Exhibit 12	Form of Common Warrant (incorporated by reference to Exhibit 4.2 to the Issuer’s Form 8-K (File No. 001-32979), filed on March 28, 2024).

Exhibit 13	Form of Prefunded Warrant to Purchase Common Stock (incorporated by reference to Exhibit 4.1 to the Issuer’s Form 8-K (File No. 001-32979), filed on March 28, 2024).

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: April 2, 2024

Santé Health Ventures I, LP		Santé Health Ventures I Annex Fund, LP

By:	SHV Management Services, LP	By:	SHV Annex Services, LP
its	General Partner	its	General Partner

By:	SHV Management Services, LLC	By:	SHV Management Services, LLC
its	General Partner	its	General Partner

By:	/s/ Kevin Lalande	By:	/s/ Kevin Lalande
	Name: Kevin Lalande		Name: Kevin Lalande
	Title: Managing Director		Title: Managing Director

SHV Management Services, LP		SHV Annex Services, LP

By:	SHV Management Services, LLC	By:	SHV Management Services, LLC
its	General Partner	its	General Partner

By:	/s/ Kevin Lalande	By:	/s/ Kevin Lalande
	Name: Kevin Lalande		Name: Kevin Lalande
	Title: Managing Director		Title: Managing Director

SHV Management Services, LLC

By:	/s/ Kevin Lalande
	Name: Kevin Lalande
	Title: Managing Director

SHV MTEM SPV, LLC		Santé Accel Ventures IV, LLC

By:	Santé Accel Ventures IV, LLC	By:	Santé Health Ventures IV, LP
Its	Managing Member	Its	Managing Member

By:	Santé Health Ventures IV, LP	By:	SHV Management Services IV, LP
Its	Managing Member	its	General Partner

By:	SHV Management Services IV, LP	By:	SHV Management Services IV, LLC
its	General Partner	its	General Partner

By:	SHV Management Services IV, LLC	By:	/s/ Kevin Lalande
its	General Partner		Name: Kevin Lalande
			Title: Managing Director
By:	/s/ Kevin Lalande
	Name: Kevin Lalande
	Title: Managing Director

Santé Health Ventures IV, LP		Joe H. Cunningham

By:	SHV Management Services IV, LP	/s/ Joe H. Cunningham
its	General Partner

By:	SHV Management Services IV, LLC
its	General Partner	Douglas D. French

By:	/s/ Kevin Lalande	/s/ Douglas D. French
	Name: Kevin Lalande
	Title: Managing Director
		Kevin Lalande

SHV Management Services IV, LP		/s/ Kevin Lalande

By:	SHV Management Services IV, LLC
its	General Partner

By:	/s/ Kevin Lalande
	Name: Kevin Lalande
	Title: Managing Director


SHV Management Services IV, LLC

By:	/s/ Kevin Lalande
	Name: Kevin Lalande
	Title: Managing Director

Exhibit(s):

Exhibit 1 

Joint Filing Agreement